The contribution of stem cell factor and granulocyte colony-stimulating factor in reducing neurodegeneration and promoting neurostructure network reorganization after traumatic brain injury.
Animals
Brain
/ drug effects
Brain Injuries, Traumatic
/ pathology
Granulocyte Colony-Stimulating Factor
/ pharmacology
Male
Mice
Mice, Inbred C57BL
Nerve Degeneration
/ pathology
Neuroprotective Agents
/ pharmacology
Recovery of Function
/ drug effects
Spatial Learning
/ drug effects
Stem Cell Factor
/ pharmacology
Functional recovery
Granulocyte colony–stimulating factor
Neural network reorganization
Neurodegeneration
Stem cell factor
Traumatic brain injury
Journal
Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503
Informations de publication
Date de publication:
01 11 2020
01 11 2020
Historique:
received:
21
04
2020
revised:
16
06
2020
accepted:
17
06
2020
pubmed:
25
6
2020
medline:
2
10
2021
entrez:
25
6
2020
Statut:
ppublish
Résumé
Traumatic brain injury (TBI) is a major cause of death and disability in young adults worldwide. TBI-induced long-term cognitive deficits represent a growing clinical problem. Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) are involved in neuroprotection and neuronal plasticity. However, the knowledge concerning reparative efficacy of SCF + G-CSF treatment in post-acute TBI recovery remains incomplete. This study aims to determine the efficacy of SCF + G-CSF on post-acute TBI recovery in young adult mice. The controlled cortical impact model of TBI was used for inducing a severe damage in the motor cortex of the right hemisphere in 8-week-old male C57BL mice. SCF + G-CSF treatment was initiated 3 weeks after induction of TBI. Severe TBI led to persistent motor functional deficits (Rota-Rod test) and impaired spatial learning function (water maze test). SCF + G-CSF treatment significantly improved the severe TBI-impaired spatial learning function 6 weeks after treatment. TBI also caused significant increases of Fluoro-Jade C positive degenerating neurons in bilateral frontal cortex, striatum and hippocampus, and significant reductions in MAP2
Identifiants
pubmed: 32579949
pii: S0006-8993(20)30356-5
doi: 10.1016/j.brainres.2020.147000
pii:
doi:
Substances chimiques
Neuroprotective Agents
0
Stem Cell Factor
0
Granulocyte Colony-Stimulating Factor
143011-72-7
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
147000Subventions
Organisme : RRD VA
ID : I01 RX002125
Pays : United States
Informations de copyright
Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.